Abingdon Health

Abingdon Health is pleased to announce 121 demonstrations of its AppDx lateral flow Smartphone reader are now available by appointment.

Patient participation is a fundamental requirement to the overall success of clinical trials. So, lateral flow based mHealth technology needs to be utilised to overcome clinical trial patient recruitment and retention issues.

A transformation that goes straight to your business' bottom line

Pharmaceutical Industry's drive to use precision medicine is definitely a move that patients and clinicians welcome in delivering the best outcomes.

Are you attending Medica this year? If you are, Abingdon Health would very much like the opportunity to meet with you.

Abingdon Health is championing the use of cost-effective near-patient testing to aid the therapeutic market share and profitability ambitions of pharmaceutical companies in an industry that is set for increased competition.

Abingdon Health is pleased to announce Seralite® – FLC Serum, which can be used to diagnose and manage patients with multiple myeloma, has been granted registration by the Brazilian Health Regulatory Agency (ANVISA)

Abingdon Health is pleased to announce the appointment of Leigh Thomas to the newly created role of Business Development Director.

A rapid test to be used as an alternative to DNA agarose gel electrophoresis

New Smartphone lateral flow reader App developed to meet a variety of individual assay and cost requirements.